Introduction: Oligella infections are rare and have been only rarely reported in the literature. This may be due to the misidentification of Oligella as a Moraxella-like organism. To the best of our knowledge, we present what we believe to be the first case report on Oligella urethralis bacteraemia in India.
Introduction
The genus Oligella, so named due to the small size of the bacilli on Gram staining, comprises two species: Oligella ureolytica and Oligella urethralis. O. urethralis, formerly Moraxella urethralis and Centers for Disease Control group M4, belongs to a group of taxonomically diverse non-fermentative Gram-negative bacilli (Rossau et al., 1987; Winn et al., 2006) . These organisms are commensals of the genitourinary tract, and most clinical isolates are from urethral samples and are often associated with an indwelling Foley catheter. Rare causes of bacteraemia, septic arthritis and pyelonephritis have been reported in the literature (Mesnard et al., 1992) .
Automated systems are used in the majority of clinical microbiology laboratories and are heavily relied on to promptly identify organisms. These systems provide rapid identification, thus reducing turnaround times and improving efficiency and cost-effectiveness (Snyder et al., 2008) . However, they are less likely to correctly identify clinically relevant non-fermenting Gram-negative bacilli.
We report a case of O. urethralis bacteraemia that was misidentified by a VITEK 2 compact system as Fransciella tularensis.
Case report
A 65-year-old female patient who lived in a rural area of Bangalore presented to the Emergency Medical Department of our hospital with predominant complaints of breathlessness for 1 day, swelling of both lower limbs and cough with expectoration for 3 days duration. The patient was a known case of diabetes mellitus, had hypertension for the past 15 years and had ischaemic heart disease 1 year previous; stage 4 chronic kidney disease was diagnosed. She was on regular treatment. On the same day of hospital admission she was shifted to the Intensive Care Unit and intubated in view of tachypnea, reduced pO 2 on arterial blood gas analysis and acidosis. ) and was started on haemodialysis. Chest X-ray was noted to be consistent with pneumothorax. Serial arterial blood gases demonstrated the progression of metabolic acidosis. The electrocardiogram demonstrated sinus tachycardia with no ST-T changes. Echocardiography revealed a dilated left-sided chamber, reduced left valve global function, ejection fraction of 42 %, mild mitral regurgitation, sclerotic aortic valve and a trivial aortic regurgitation.
Blood culture was performed in BacT/ALERT 3D (bioMér-ieux) aerobic adult blood culture bottles. As the patient was intubated, sputum sample could not be obtained. However, a tracheal aspirate yielded no growth. After debridement of the ulcer on the left foot, the pus sample was sent for culture and yielded Klebsiella pneumoniae.
Based on the above clinical and laboratory findings, a primary diagnosis of sepsis and pneumothorax with acute respiratory distress syndrome, and a secondary diagnosis of type II diabetes mellitus, left diabetic foot, with ischaemic heart disease and hypertension, was made.
After 24 h incubation in aerobic blood culture bottles, bacterial growth was detected (based on spectrophotometric CO 2 detection). Gram staining revealed a Gram-negative coccobacillus. Subculture performed on 5 % sheep blood agar yielded confluent growth of a single type of grey-white, opaque, non-haemolytic colonies after 48 h incubation. No growth was noted on MacConkey agar plates. The organism was identified as F. tularensis by an automated VITEK 2 Compact GN ID card (bioMérieux) bacterial identification system with 99 % probability. This identification result was surprising, as this bacteria species has never been identified and reported in India from known publications. Antimicrobial susceptibility testing was not performed due to inadequate laboratory safety facilities for handling this category A biological agent. To confirm the isolate, we sent it for 16S rRNA gene sequencing at VRF Referral Laboratory, Chennai, India. A second blood culture sample collected on day 5 remained sterile even after extended incubation.
The patient was treated empirically with injectable piperacillin/tazobactum 2.25 mg every 8 h and injectable imipenem 250 mg every 12 h for 6 days. From the blood cultures, a single bacterial species was isolated and identified as F. tularensis. On day 5, injectable streptomycin 4 mg kg 21 was started on alternate days in modified dose as per renal clearance.
The patient's general condition remained stable with no clinical improvement throughout the hospital stay; the patient finally deteriorated and succumbed to death on day 14. On the day of patient demise, the report of 16S rRNA gene sequencing was received and the isolate was identified as O. urethralis. Only partial sequencing was performed, submitted to GenBank and given GenBank accession number KF280285.1.
Although the patient had expired, an antibiotic sensitivity test was still performed on this O. urethralis isolate for research purposes. As there are no validated testing methods and based on little documentation available in the literature, an antibiogram was performed by the Kirby Bauer disc diffusion method (Alireza et al., 2006) . The isolate was found to be sensitive to imipenem, meropenem, piperacillin/tazobactum, tobramycin, ceftazidime and amikacin, and resistant to penicillin, ampicillin and cotrimoxazole.
Discussion
A review of previously published case reports yielded only five cases of Oligella bacteraemia:, four cases caused by Oligella ureolytica and only one case reported of Oligella urethralis bacteraemia (Baqi & Mazzulli, 1996; Baruah et al., 2014) . The clinical significance of Oligella urethralis bacteraemia is unknown and the mechanism of infection remains unclear, but it appears to occur in conjunction with compromising underlying illness, as seen in the cases reported so far. Available literature also suggests that Oligella infec- tion responds quickly to antibiotics. Amongst the reported cases, it is seen that only one patient died due to secondary fungaemia and the remaining responded well to antibiotics.
In our case, as the second blood culture performed after starting empiric antibiotics remained sterile even after extended incubation, we assume Oligella bloodstream infection was cleared as the isolate was sensitive to imipenem and piperacillin/tazobactum. However, we could not ascertain this as the patient's clinical condition remained the same and she died due to additional comorbid conditions.
To the best of our knowledge, we believe this to be the first case report on Oligella urethralis bacteraemia in India.
Recently, a case report on Oligella ureolytica bacteraemia was reported by Baruah et al. (2014) . In clinical laboratories, most bacteria are routinely identified by biochemical characteristics using a commercial kit or automated identification system, such as API and VITEK. This case illustrates the challenge for clinicians when suspecting this rare disease and the failure of automated systems to reliably identify O. urethralis -a rare and emerging pathogen. However, the results from automated systems should be analysed critically, taking into consideration the reliability of these systems for accurate identification of slow-growing, rare and biochemically inert organisms, such as F. tularensis, Burkholderia pseudomallei, Brucella spp. and Yersinia pestis (ASM, 2014). These isolates should be confirmed with a second method such as 16S sequencing and/or matrix-assisted laser desorption/ ionization time-of-flight MS.
In conclusion, molecular methods should be considered to correctly identify such rare organisms and this will likely impact patient care in addition to microbiologic research. Hence, strict microbiological vigilance is required in the identification of these clinically relevant non-fermenting Gram-negative bacilli.
